These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17932473)

  • 21. Novel ways to preserve the peritoneal membrane.
    Sajwani SH; Bargman JM
    Adv Perit Dial; 2012; 28():37-41. PubMed ID: 23311211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A commercially available PD fluid with high pH and low GDP induces different morphological changes of rat peritoneum in intermittent PD.
    Jonasson P; Braide M
    Adv Perit Dial; 1998; 14():48-53. PubMed ID: 10649690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content.
    Schmitt CP; von Heyl D; Rieger S; Arbeiter K; Bonzel KE; Fischbach M; Misselwitz J; Pieper AK; Schaefer F;
    Nephrol Dial Transplant; 2007 Jul; 22(7):2038-44. PubMed ID: 17420168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers in peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan.
    Kawanishi H; Fujimori A; Tsuchida K; Takemoto Y; Tomo T; Minakuchi J; Yamamoto T; Kim M; Numata A; Choh S; Naito H;
    Adv Perit Dial; 2005; 21():134-8. PubMed ID: 16686304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes.
    Miyata T; Devuyst O; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 2002 Feb; 61(2):375-86. PubMed ID: 11849377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis].
    Penar J; Weyde W; Krajewska M; Madziarska K; Gołebiowski T; Szymczak M; Kłak R; Klinger M
    Postepy Hig Med Dosw (Online); 2009 Apr; 63():200-4. PubMed ID: 19502680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation from sterile dialysis solutions and the longevity of the peritoneal barrier.
    Flessner MF
    Clin Nephrol; 2007 Dec; 68(6):341-8. PubMed ID: 18184514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peritoneal sclerosis in children under treatment with peritoneal dialysis].
    Moriya S; Koshino H; Iitaka K; Kasai N
    Nihon Jinzo Gakkai Shi; 2001 May; 43(5):378-83. PubMed ID: 11510225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
    Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
    Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
    de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatible peritoneal dialysis solutions: do we have one?
    Chaudhary K; Khanna R
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morpho-functional study of peritoneum in peritoneal dialysis].
    Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
    G Ital Nefrol; 2003; 20(2):160-5. PubMed ID: 12746801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and local impact of glucose and glucose degradation products in peritoneal dialysis solution.
    Kim YL; Cho JH; Choi JY; Kim CD; Park SH
    J Ren Nutr; 2013 May; 23(3):218-22. PubMed ID: 23510669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous peritoneal membrane rupture with extravasation of peritoneal fluid into the lower limbs and flank in a peritoneal dialysis patient.
    Benaroia M; Morton AR; Cheeseman FD; Garland JS; Toffelmire EB
    Perit Dial Int; 2008; 28(5):554-7. PubMed ID: 18708555
    [No Abstract]   [Full Text] [Related]  

  • 40. How peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease-what can we learn for future treatment?
    Bartosova M; Zarogiannis SG; Schmitt CP;
    Mol Cell Pediatr; 2022 May; 9(1):9. PubMed ID: 35513740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.